Journal Article (Letter)

DKFZ-2023-00531

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al.

Immisch, L.DKFZ* ; Papafotiou, G.DKFZ* ; Popp, O. ; Mertins, P. ; Blankenstein, T. ; Willimsky, G.DKFZ*

2023
BioMed Central London

This record in other databases:  

Please use a persistent id in citations: doi:10.1136/jitc-2023-006784

Keyword(s): Antigens, Neoplasm ; Immunotherapy ; Immunotherapy, Adoptive

---

Contributing Institute(s):

1. DKTK BE zentral (BE01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2023

---

Database coverage:
; ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 10 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---